Brimonidine tartrate and Timolol maleate
Brimonidine tartrate and Timolol maleate is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand names including Brimonidine tartrate and Timolol maleate, BRIMONIDINE TARTRATE AND TIMOLOL MALEATE. Available dosage forms: solution/ drops, solution.
Drug details
- Generic Name
- Brimonidine tartrate and Timolol maleate
- Brand Names
- Brimonidine tartrate and Timolol maleate, BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
- Application Number
- ANDA201949
- Sponsor
- NorthStar RxLLC
- NDC Codes
- 3
- Dosage Forms
- SOLUTION/ DROPS, SOLUTION
- Routes
- OPHTHALMIC
- Active Ingredients
- BRIMONIDINE TARTRATE, TIMOLOL MALEATE
Indications and Usage
1 INDICATIONS AND USAGE Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution, 0.2%/0.5% is indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day. Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution is a combination of brimonidine tartrate, an alpha-adrenergic receptor agonist, and timolol maleate, a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. The IOP-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of timolol maleate ophthalmic solution, 0.5% dosed twice a day and brimonidine tartrate ophthalmic solution, 0.2% dosed three times per day.